Form 4 Filing for Abeona Therapeutics Inc.

This filing reports a transaction by Joseph Vazzano, Chief Financial Officer of Abeona Therapeutics Inc. On July 21, 2026, Mr. Vazzano disposed of 1,478 shares of Common Stock at a price of $6.53 per share. This disposal was made to cover tax withholding obligations upon the vesting of restricted stock awards. Following this transaction, Mr. Vazzano directly owns 492,079 shares of Common Stock.